GRANULES CONSUMER HEALTH Guaifenesin Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Guaifenesin from India and how much does GRANULES CONSUMER HEALTH import?

India exports Guaifenesin to 278 buyers globally worth $14.5M. GRANULES CONSUMER HEALTH imports $4.5M (21.7% market share) with 121 shipments from UNITED STATES.

Q: What is the average order value for GRANULES CONSUMER HEALTH's Guaifenesin imports?

GRANULES CONSUMER HEALTH's average Guaifenesin order value is $37.6K per consignment, based on 121 shipments totaling $4.5M.

Q: Who supplies Guaifenesin to GRANULES CONSUMER HEALTH?

GRANULES CONSUMER HEALTH sources Guaifenesin from 1 verified supplier: GRANULES INDIA LIMITED ($4.5M, 100.0%). Based on 121 customs records.

Q: How does GRANULES CONSUMER HEALTH compare to other Guaifenesin importers?

GRANULES CONSUMER HEALTH ranks #1 among 278 Guaifenesin importers from India with 21.7% market share and 121 shipments.

Q: Who are the top Guaifenesin importers from India?

Top Guaifenesin importers: GRANULES CONSUMER HEALTH ($5.8M), SPIRIT PHARMACEUTICALS LLC ($1.8M), GRANULES USA INC. ($905.1K), AGIO RUS LLC ($837.4K), IBN SINA SCIENTIFIC BUREAU ($758.9K).

Suresh Sormare

Guaifenesin

India Pharmaceutical Trade Intelligence

$26.7M151 Suppliers77 CountriesHS 30049099

ExportsIndia → UNITED STATES69.6%India → IRAQ3.4%

#1 Supplier: GRANULES INDIA #1 Buyer: GRANULES CONSUMER

GRANULES CONSUMER HEALTH — Guaifenesin Importer #1 | $4.5M Trade Value | TransData Nexus | TransData Nexus

GRANULES CONSUMER HEALTH — Guaifenesin Importer Profile

Pharmaceutical Importer · #1 buyer for Guaifenesin · $4.5M import value · 121 shipments · UNITED STATES · DGFT Verified

GRANULES CONSUMER HEALTH is the #1 importer of Guaifenesin from India with $4.5M in import value and 121 verified shipments. GRANULES CONSUMER HEALTH holds a 21.7% market share in Guaifenesin imports based in UNITED STATES. The company sources from 1 verified supplier across 59 formulations shipped to 2 countries. Overall, GRANULES CONSUMER HEALTH imports 8 pharmaceutical products worth $110.4M across 4 therapeutic categories.

GRANULES CONSUMER HEALTH — Guaifenesin Import Profile: Suppliers, Formulations & Sources

GRANULES CONSUMER HEALTH — Guaifenesin import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Guaifenesin to GRANULES CONSUMER HEALTH?

Verified from 121 customs shipment records

Supplier	Value	Shipments	% Share
GRANULES INDIA LIMITED	$4.5M	121	100.0%

GRANULES CONSUMER HEALTH sources Guaifenesin from 1 verified Indian supplier based on 121 customs records. The primary supplier is GRANULES INDIA LIMITED accounting for 100.0% of imports.

How Does GRANULES CONSUMER HEALTH Compare to Nearest Guaifenesin Importers?

Buyers ranked immediately above and below #1 by import value

#	Buyer

Where Does GRANULES CONSUMER HEALTH Import Guaifenesin To?

Destination countries from 121 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$4.5M	120	98.9%
UNITED STATES OF AMERICA	$50.0K	1	1.1%

GRANULES CONSUMER HEALTH imports Guaifenesin to 2 countries. The primary destination is UNITED STATES receiving 98.9% of shipments worth $4.5M.

What Guaifenesin Formulations Does GRANULES CONSUMER HEALTH Import?

Formulation	Value	Shipments
GUAIFENESIN EXTENDED RELEASE TABLETS 600	$360.2K	10
GUAIFENESIN EXTENDED RELEASE TABLETS 600MG	$359.1K	9
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG-14'S	$300.0K	6
GUAIFENESIN EXTENDED RELEASE TABLETS 120	$200.0K	4
GUAIFENESIN EXTENDED-RELEASE TABLETS 600MGNOS	$154.7K	6
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG-14S(201,000.000PAC)	$150.0K	3
GUAIFENESIN EXTENDED-RELEASE TABLETS 1200MGNOS	$148.8K	3
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MGNOS	$148.1K	3
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG/GUSA(2,860.000PAC)	$147.1K	3
GUAIFENESIN EXTENDED RELEASE TABLETS 600MG 500#S(9336.000PAC)NOS	$132.5K	3

GRANULES CONSUMER HEALTH imports 59 distinct Guaifenesin formulations from India. The top formulation is GUAIFENESIN EXTENDED RELEASE TABLETS 600 with 10 shipments worth $360.2K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Guaifenesin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: GRANULES CONSUMER HEALTH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as GRANULES CONSUMER HEALTH's capped import value divided by total capped export value for Guaifenesin across all Indian exporters.
5.Verified Records: This page is backed by 121 individual customs records matching GRANULES CONSUMER HEALTH importing Guaifenesin, covering 59 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 77+ countries, 278+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Guaifenesin

Guaifenesin

GRANULES CONSUMER HEALTH — Guaifenesin Importer Profile

GRANULES CONSUMER HEALTH — Guaifenesin Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Guaifenesin to GRANULES CONSUMER HEALTH?

How Does GRANULES CONSUMER HEALTH Compare to Nearest Guaifenesin Importers?

Where Does GRANULES CONSUMER HEALTH Import Guaifenesin To?

What Guaifenesin Formulations Does GRANULES CONSUMER HEALTH Import?

Regulatory Requirements: Importing Guaifenesin into United States

Regulatory Authority

Approval Process for Generic Guaifenesin

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Guaifenesin from India and How Much Does GRANULES CONSUMER HEALTH Import?

What Is the Average Order Value for GRANULES CONSUMER HEALTH's Guaifenesin Imports?

Who Supplies Guaifenesin to GRANULES CONSUMER HEALTH?

How Does GRANULES CONSUMER HEALTH Compare to Other Guaifenesin Importers?

About GRANULES CONSUMER HEALTH

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Guaifenesin Import Data for GRANULES CONSUMER HEALTH

GRANULES CONSUMER HEALTH × Guaifenesin

Company Overview

Top Products by GRANULES CONSUMER HEALTH

Related Analysis

Need Detailed Import Data?

Data Source

1	GRANULES CONSUMER HEALTH ★	UNITED STATES	$5.8M	116	$50.0K
2	SPIRIT PHARMACEUTICALS LLC	UNITED STATES	$1.8M	36	$50.0K
4	GRANULES USA INC.	UNITED STATES	$905.1K	25	$36.2K